Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Development of new therapeutics for Alzheimer´s disease

Reference number
Coordinator Göteborgs Universitet - Institutionen för neurovetenskap och fysiologi
Funding from Vinnova SEK 1 766 530
Project duration July 2015 - June 2018
Status Completed

Purpose and goal

The lack of treatments of age-related disorders, such as Alzheimer´s disease (AD), is a global challenge for our society. This project, which is a collaboration between the research group of associate professor Petronella Kettunen at University of Gothenburg (including the newly formed Centre for Cognitive Medicine, CCM) and biotech/pharmaceutical companies in the Oxford region, aims at combining unique methods and hypotheses to develop novel diagnostics and therapeutics for AD.

Expected results and effects

The overall goal of this project is to increase the understanding of AD to allow for the development of future AD diagnostics and therapies based on compounds that modulate specific pathways that affects neurodegeneration in AD. In addition, this collaboration will also mean new connections between University of Gothenburg and the Oxford region and enhance the competitiveness of academia and the healthcare and private sectors in Sweden.

Planned approach and implementation

The project will include work in all phases of the drug development process, from preclinical development to planning of future clinical trials. The complementary methods, strengths and expertise of the partners will contribute to a successful long-term collaboration. During the project period, Dr Kettunen will also acquire highly relevant skills in innovation,leadership and project management.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 21 January 2019

Reference number 2015-01532

Page statistics